Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
about
Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitisCefprozil: a review.Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infectionsMultiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteersComparison of cefprozil and cefaclor for treatment of acute urinary tract infections in womenDermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique.Phase I study of multiple-dose cefprozil and comparison with cefaclor.Comparison of the effects of food on the pharmacokinetics of cefprozil and cefaclor.Effect of antacid on the bioavailability of cefprozil.Absolute bioavailability of cefprozil after oral administration in beagles.Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.Comparative studies of cefprozil in the management of skin and soft-tissue infections.Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin.Comparative target site pharmacokinetics of immediate- and modified-release formulations of cefaclor in humans.Pharmacokinetic interactions of cefprozil with food, propantheline, metoclopramide, and probenecid in healthy volunteers.Pharmacokinetics of cefprozil in healthy subjects and patients with hepatic impairment.Pediatric tonsillopharyngitis--an evaluation of cefprozil in Indian patients.
P2860
Q33743937-DFEEA2C9-52BA-4050-B744-05F7DB36DE18Q35169148-9F5560E1-A357-4CCE-8C1D-6CC569413AF3Q35820708-36F8B87C-E375-46CC-9794-E85F431AC5F4Q35843432-B3F45052-F5DA-4FC7-90C0-27F006D62864Q36755115-AC7954C2-9508-4AD9-B0AA-7DCA389DBF9BQ37335289-28E935B0-CFA3-4BAA-A4C5-92DCA1EE14B7Q39816259-9E0FE906-D334-4649-8A09-C23E82A2DB1DQ39816273-9A314503-717C-4EAB-AA1F-8E02366372C8Q39869228-ED5DF813-EA56-4A9B-BA72-560543C23291Q39875925-78CCE320-25BC-4738-B548-B489023CB21FQ40612602-A2B9C5AC-774A-4BD6-889E-B25B0F271FD2Q40612614-5AC73C7B-64C5-4741-B046-FA8ED480FE0CQ40771012-F78E6C8F-82A3-4506-A7F6-1725FCD95D0FQ43949808-E3022ECC-B3C6-448F-BF90-C6908F55572EQ44741967-E3940D3F-7CD1-40ED-8C56-192532927772Q44874024-40CAF621-F2F6-431D-9C22-E7E514B2C738Q44997841-D929C535-E6D6-4C74-B0AA-0667F021C09E
P2860
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
@en
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
@nl
type
label
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
@en
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
@nl
prefLabel
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
@en
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
@nl
P2093
P2860
P356
P1476
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
@en
P2093
C R Gleason
K A Pittman
R B Wilber
R H Barbhaiya
U A Shukla
P2860
P304
P356
10.1128/AAC.34.6.1204
P407
P577
1990-06-01T00:00:00Z